Large regenerative nodules in a patient with budd-chiari syndrome after TIPS positioning while on the liver transplantation list diagnosed by Gd-EOB-DTPA MRI

Hepatobiliary and Pancreatic Diseases International

Volumn 10, Issue 4, 2011, Pages 439-442

  Renzulli, Matteo ^a   Lucidi, Vincenzo ^a   Mosconi, Cristina ^a   Quarneti, Chiara ^a   Giampalma, Emanuela ^a   Golferi, Rita ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Budd chiari syndrome; Gd EOB DTPA enhanced MRI; Large regenerative nodules

Indexed keywords

GADOXETIC ACID;

ADULT; ARTICLE; BUDD CHIARI SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATOBILIARY DISEASE; HEPATOBILIARY SYSTEM; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LARGE REGENERATIVE NODULE; LIVER CELL CARCINOMA; LIVER INJURY; LIVER NODULE; LIVER SCINTISCANNING; LIVER TRANSPLANTATION; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT POSITIONING; SURGICAL TECHNIQUE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

EID: 79961201865     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(11)60075-1     Document Type: Article

References (16)

1. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995;22:983-993.
2. Brancatelli G, Federle MP, Grazioli L, Golferi R, Lencioni R. Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging fndings with clinicopathologic correlation. AJR Am J Roentgenol 2002; 178:877-883.
3. Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR Am J Roentgenol 1987;148: 717-722.
4. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998;27:488-496.
5. Vilgrain V, Lewin M, Vons C, Denys A, Valla D, Flejou JF, et al. Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 1999;210:443-450.
6. Grazioli L, Alberti D, Olivetti L, Rigamonti W, Codazzi F, Matricardi L, et al. Congenital absence of portal vein with nodular regenerative hyperplasia of the liver. Eur Radiol 2000; 10:820-825.
7. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004;350:578-585.
8. Tanju S, Erden A, Ceyhan K, Soygür IT, Bozkaya H, Erden I. Contrast-enhanced MR angiography of benign regenerative nodules following TIPS shunt procedure in Budd-Chiari syndrome. Turk J Gastroenterol 2004;15:173-177.
9. Ames JT, Federle MP, Chopra K. Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver. Clin Radiol 2009;64: 1190-1195.
10. Kim T, Baron RL, Nalesnik MA. Infarcted regenerative nodules in cirrhosis: CT and MR imaging fndings with pathologic correlation. AJR Am J Roentgenol 2000;175:1121-1125.
11. Takayasu K, Muramatsu Y, Moriyama N, Wakao F, Makuuchi M, Takayama T, et al. Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases. Am J Gastroenterol 1994;89:249-253.
12. Hamm B, Staks T, Mühler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-792.
13. Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67.
14. Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996;199:177-183.
15. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liver-specifc contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6:43-52.
16. Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009;44:793-798.